ストックスクリーナーアプリを入手
30.84
6.64%
1.92
プレマーケット:
30.41
-0.43
-1.39%
前日終値:
$28.92
開ける：
$28.59
24時間の取引高:
1.38M
Relative Volume:
1.20
時価総額：
$3.68B
収益：
$10.12M
当期純損益:
$-280.49M
株価収益率:
-10.67
EPS:
-2.89
ネットキャッシュフロー:
$-188.51M
1週間 パフォーマンス:
+14.01%
1か月 パフォーマンス:
-3.08%
6か月 パフォーマンス:
-31.65%
1年 パフォーマンス:
+203.54%
1日の値動き範囲:
$28.59
$31.30
1週間の範囲:
$27.49
$31.30
52週間の値動き範囲:
$9.93
$56.00
Avidity Biosciences Inc Stock (RNA) Company Profile
名前
Avidity Biosciences Inc
セクター
電話
858-401-7900
住所
10578 SCIENCE CENTER DRIVE, SAN DIEGO, CA
RNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RNA
Avidity Biosciences Inc
|
30.84 | 3.68B | 10.12M | -280.49M | -188.51M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Avidity Biosciences Inc Stock (RNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-20 | 開始されました | H.C. Wainwright | Buy |
| 2024-11-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-09-24 | 開始されました | Goldman | Buy |
| 2024-08-28 | 開始されました | Barclays | Overweight |
| 2024-05-03 | 開始されました | BofA Securities | Buy |
| 2024-03-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-05-22 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-03-31 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-07-20 | 開始されました | Chardan Capital Markets | Buy |
| 2022-07-12 | 開始されました | Raymond James | Strong Buy |
| 2021-09-07 | 開始されました | Evercore ISI | Outperform |
| 2021-06-17 | 開始されました | Needham | Buy |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-07-07 | 開始されました | Cowen | Outperform |
| 2020-07-07 | 開始されました | Credit Suisse | Outperform |
| 2020-07-07 | 開始されました | SVB Leerink | Outperform |
| 2020-07-07 | 開始されました | Wells Fargo | Overweight |
すべてを表示
Avidity Biosciences Inc (RNA) 最新ニュース
Equities Analysts Set Expectations for RNA Q1 Earnings - MarketBeat
Royal Bank of Canada Reiterates Outperform Rating for Avidity Biosciences (NASDAQ:RNA) - MarketBeat
Exciting News from Avidity Biosciences! New Opportunities Await! - Qhubo
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StreetInsider.com
Avidity Biosciences Awards New Employee Stock Options and RSUs Worth $304K - StockTitan
12 Biotech Stocks with the Biggest Upside Potential - Insider Monkey
Avidity Biosciences, Inc. (RNA): The Biotech Stock with Biggest Upside Potential - Insider Monkey
Avidity Set To File First Of Three Muscular Dystrophy Drugs In 2025 - News & Insights
Avidity Biosciences Inc (RNA-Q) QuotePress Release - The Globe and Mail
Avidity Biosciences Becomes Oversold (RNA) - Nasdaq
Avidity Biosciences (NASDAQ:RNA) Sees Large Volume IncreaseHere's Why - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Given Buy Rating at HC Wainwright - MarketBeat
Analyst Expectations For Avidity Biosciences's Future - Benzinga
JPMorgan Chase & Co. Has $21.45 Million Stock Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA) - Defense World
Avidity Biosciences Announces Inducement Grants Under Nasdaq Lis - GuruFocus.com
Avidity Biosciences, Inc. Announces 2025 Upcoming Clinical and Regulatory Highlights - Marketscreener.com
Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025 - PR Newswire
Principal Financial Group Inc. Reduces Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA) - Defense World
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives $64.36 Average Target Price from Analysts - MarketBeat
Why Is Avidity Biosciences, Inc. (RNA) Among the Best Multibagger Stocks to Buy Right Now? - Insider Monkey
Companies Like Avidity Biosciences (NASDAQ:RNA) Are In A Position To Invest In Growth - Simply Wall St
12 Best Multibagger Stocks to Buy Right Now - Insider Monkey
Avidity Biosciences (NASDAQ:RNA) Trading Down 5.4%What's Next? - MarketBeat
Avidity Biosciences Joins Patient and Advocacy Communities in Ra - GuruFocus.com
Franklin Resources Inc. Acquires 50,908 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Chardan Capital Has Negative Outlook of RNA FY2024 Earnings - MarketBeat
Avidity Biosciences' CSTO Flanagan sells $416,153 in stock By Investing.com - Investing.com Australia
Avidity Biosciences CFO sells $364,191 in stock By Investing.com - Investing.com Australia
Avidity Biosciences CEO Sarah Boyce sells $1.04 million in stock - Investing.com India
Avidity Biosciences CHRO Teresa McCarthy sells $364,191 in stock By Investing.com - Investing.com Australia
Avidity Biosciences (NASDAQ:RNA) Shares Up 3.2%Still a Buy? - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Now Covered by Analysts at HC Wainwright - MarketBeat
Avidity Biosciences shares initiated with Buy on establishment By Investing.com - Investing.com UK
What 8 Analyst Ratings Have To Say About Avidity Biosciences - Benzinga
Avidity Biosciences CFO sells $364,191 in stock - Investing.com India
Avidity Biosciences CEO Sarah Boyce sells $1.04 million in stock By Investing.com - Investing.com South Africa
Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells 12,742 Shares of Stock - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) CEO Sells $1,040,384.30 in Stock - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) CFO Michael F. Maclean Sells 11,151 Shares - MarketBeat
Avidity Biosciences CHRO Teresa McCarthy sells $364,191 in stock - Investing.com
Avidity Biosciences' CSTO Flanagan sells $416,153 in stock - Investing.com India
Avidity Biosciences CHRO Teresa McCarthy sells $831,605 in stock By Investing.com - Investing.com Nigeria
Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells 25,000 Shares of Stock - MarketBeat
Avidity Biosciences CHRO Teresa McCarthy sells $831,605 in stock - Investing.com India
Geode Capital Management LLC Buys 328,606 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Shares Gap DownShould You Sell? - MarketBeat
Avidity Biosciences Inc (RNA) 財務データ
収益
当期純利益
現金流量
EPS
4.81%
大文字化:
|
ボリューム (24 時間):